These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 18293205)
1. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Teixeira PG; Cabral AC; Andrade SP; Reis ZS; da Cruz LP; Pereira JB; Martins BO; Rezende CA Hypertens Pregnancy; 2008; 27(1):65-73. PubMed ID: 18293205 [TBL] [Abstract][Full Text] [Related]
2. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861 [TBL] [Abstract][Full Text] [Related]
3. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor. Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705 [TBL] [Abstract][Full Text] [Related]
4. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808 [TBL] [Abstract][Full Text] [Related]
5. Circulating angiogenic factors and the risk of preeclampsia. Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923 [TBL] [Abstract][Full Text] [Related]
6. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin. Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study. Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669 [TBL] [Abstract][Full Text] [Related]
8. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809 [TBL] [Abstract][Full Text] [Related]
9. Placental growth factor: a predictive marker for preeclampsia? Schmidt M; Dogan C; Birdir C; Kuhn U; Gellhaus A; Kimmig R; Kasimir-Bauer S Gynakol Geburtshilfliche Rundsch; 2009; 49(2):94-9. PubMed ID: 19346754 [TBL] [Abstract][Full Text] [Related]
10. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia. Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929 [TBL] [Abstract][Full Text] [Related]
11. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study. Mundim GJ; Paschoini MC; Araujo Júnior E; Da Silva Costa F; Rodrigues Júnior V Arch Gynecol Obstet; 2016 Feb; 293(2):369-75. PubMed ID: 26205065 [TBL] [Abstract][Full Text] [Related]
12. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health? Moe K; Heidecke H; Dechend R; Staff AC Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696 [TBL] [Abstract][Full Text] [Related]
13. Plasma sFlt-1-to-PlGF ratio is correlated with inflammatory but not with oxidative stress in Chinese preeclamptic women. Ouyang YQ; Li SJ; Zhang Q; Xiang WP; Shen HL; Chen HP; Chen H; Chen HZ Arch Gynecol Obstet; 2009 Jul; 280(1):91-7. PubMed ID: 19099313 [TBL] [Abstract][Full Text] [Related]
14. [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia]. Semczuk-Sikora A; Krzyzanowski A; Kwiatek M; Semczuk M Ginekol Pol; 2007 Nov; 78(11):873-6. PubMed ID: 18306920 [TBL] [Abstract][Full Text] [Related]
15. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253 [TBL] [Abstract][Full Text] [Related]
17. Placental growth factor in the cerebrospinal fluid of women with preeclampsia. Foyouzi N; Norwitz ER; Tsen LC; Buhimschi CS; Buhimschi IA Int J Gynaecol Obstet; 2006 Jan; 92(1):32-7. PubMed ID: 16242694 [TBL] [Abstract][Full Text] [Related]
18. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Livingston JC; Chin R; Haddad B; McKinney ET; Ahokas R; Sibai BM Am J Obstet Gynecol; 2000 Dec; 183(6):1554-7. PubMed ID: 11120527 [TBL] [Abstract][Full Text] [Related]
19. Placenta growth factor is not an early marker for the development of severe preeclampsia. Livingston JC; Haddad B; Gorski LA; Neblett P; Ahokas RA; Ramsey R; Sibai BM Am J Obstet Gynecol; 2001 May; 184(6):1218-20. PubMed ID: 11349191 [TBL] [Abstract][Full Text] [Related]
20. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Krauss T; Pauer HU; Augustin HG Hypertens Pregnancy; 2004; 23(1):101-11. PubMed ID: 15117604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]